Related Experiment Videos
Human proinsulin-specific antigenic determinants identified by monoclonal antibodies
Diabetes
|October 1, 1984
Summary
Monoclonal antibodies mapped antigenic sites on human proinsulin (HPI) and human C-peptide (HCP). Specific antibodies identified determinants on HPI linked to B-chain and a 3D structure in HCP, independent of insulin structure.
Area of Science:
- Immunology
- Biochemistry
- Endocrinology
Background:
- Human proinsulin (HPI) is a precursor to insulin and C-peptide.
- Understanding HPI processing and antigenic sites is crucial for diabetes research.
Purpose of the Study:
- To map antigenic determinants on HPI and cross-reactive sites on human C-peptide (HCP).
- To characterize the binding of specific monoclonal antibodies (Mabs) to HPI intermediates.
Main Methods:
- Utilized various forms of purified, partially converted HPI intermediates.
- Employed HPI-specific and HCP-cross-reactive mouse and rat monoclonal antibodies (Mabs).
- Assessed antibody binding efficiency to different HPI forms and fragments.
Main Results:
- Two HPI-specific Mabs identified a determinant (GS) at the B-chain/C-peptide linkage site (Arg-Arg 31-32).
- A rat Mab (GN-VIIB6) recognized a 3D determinant (GN) within the C-peptide segment (residues 40-45 and 57-63).
- The GN determinant remained intact in denatured HPI, independent of insulin moiety structure.
Conclusions:
- The GS determinant is located at the Arg-Arg cleavage site of HPI.
- The GN determinant is a stable, three-dimensional structure within the C-peptide segment of HPI.
- Formation of the GN determinant does not require ordered structure in the insulin moiety of HPI.